These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37260256)

  • 1. Assessing the reliability of the CD4 depletion model in the presence of Ending the HIV Epidemic initiatives.
    Tang ME; Goyal R; Anderson CM; Mehta SR; Little SJ
    AIDS; 2023 Aug; 37(10):1617-1624. PubMed ID: 37260256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the sensitivity of jurisdictional heterogeneity and jurisdictional mixing in national level HIV prevention analyses: context of the U.S. ending the HIV epidemic plan.
    Tatapudi H; Gopalappa C
    BMC Med Res Methodol; 2022 Nov; 22(1):304. PubMed ID: 36435750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. America's HIV Epidemic Analysis Dashboard: Protocol for a Data Resource to Support Ending the HIV Epidemic in the United States.
    Sullivan PS; Woodyatt CR; Kouzouian O; Parrish KJ; Taussig J; Conlan C; Phillips H
    JMIR Public Health Surveill; 2022 Feb; 8(2):e33522. PubMed ID: 35142639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Can Progress Toward Ending the Human Immunodeficiency Virus Epidemic in the United States Be Monitored?
    Mitchell KM; Maheu-Giroux M; Dimitrov D; Moore M; Hughes JP; Donnell D; Beyrer C; El-Sadr WM; Cohen MS; Boily MC
    Clin Infect Dis; 2022 Aug; 75(1):163-169. PubMed ID: 34849635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing linear CD4 decline quantifying diagnosis delay after HIV seroconversion: assessing the linearity assumption of CD4 decline.
    Robertson MM; Braunstein SL; Hoover DR; Li S; Nash D
    Ann Epidemiol; 2020 Dec; 52():1-6. PubMed ID: 32791198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing HIV Prevention Efforts to Achieve EHE Incidence Targets.
    Jacobson EU; Hicks KA; Carrico J; Purcell DW; Green TA; Mermin JH; Farnham PG
    J Acquir Immune Defic Syndr; 2022 Apr; 89(4):374-380. PubMed ID: 35202046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Undiagnosed HIV Estimates Computed from the CD4 Depletion Model in a Rural, Medium-low HIV Prevalence State.
    Nguyen VT; Jatta A; Mayer R; Meier JL
    AIDS Behav; 2022 Feb; 26(2):613-622. PubMed ID: 34355286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring Changes in Racial/Ethnic Disparities of HIV Diagnosis Rates Under the "Ending the HIV Epidemic: A Plan for America" Initiative.
    McCree DH; Chesson H; Bradley ELP; Williams A; Gant Z; Geter A
    Public Health Rep; 2020; 135(5):685-690. PubMed ID: 32762633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the U.S. Ending the HIV Epidemic jurisdictions.
    Sullivan PS; Mouhanna F; Mera R; Pembleton E; Castel AD; Jaggi C; Jones J; Kramer MR; McGuinness P; McCallister S; Siegler AJ
    Ann Epidemiol; 2020 Apr; 44():16-30. PubMed ID: 32088073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling an integrated HIV prevention and care continuum to achieve the Ending the HIV Epidemic goals.
    Jenness SM; Johnson JA; Hoover KW; Smith DK; Delaney KP
    AIDS; 2020 Nov; 34(14):2103-2113. PubMed ID: 32910062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of the Undiagnosed Intervals of HIV-Infected Individuals by a Modified Back-Calculation Method for Reconstructing the Epidemic Curves.
    Wong NS; Wong KH; Lee MP; Tsang OT; Chan DP; Lee SS
    PLoS One; 2016; 11(7):e0159021. PubMed ID: 27403882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision tree for accurate infection timing in individuals newly diagnosed with HIV-1 infection.
    Verhofstede C; Fransen K; Van Den Heuvel A; Van Laethem K; Ruelle J; Vancutsem E; Stoffels K; Van den Wijngaert S; Delforge ML; Vaira D; Hebberecht L; Schauvliege M; Mortier V; Dauwe K; Callens S
    BMC Infect Dis; 2017 Nov; 17(1):738. PubMed ID: 29187159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving the "Ending the HIV Epidemic in the U.S." incidence reduction goals among at-risk populations in the South.
    Hamilton DT; Hoover KW; Smith DK; Delaney KP; Wang LY; Li J; Hoyte T; Jenness SM; Goodreau SM
    BMC Public Health; 2023 Apr; 23(1):716. PubMed ID: 37081482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the US National HIV Strategy and Ending the HIV Epidemic Initiative.
    McGee KS
    Nurs Clin North Am; 2024 Jun; 59(2):297-308. PubMed ID: 38670696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of delay to diagnosis and incidence in HIV using indirect evidence of infection dates.
    Stirrup OT; Dunn DT
    BMC Med Res Methodol; 2018 Jun; 18(1):65. PubMed ID: 29945571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of local epidemic conditions in monitoring progress towards HIV epidemic control in Kenya: a modelling study.
    Anderson SJ; Garnett GP; Enstone J; Hallett TB
    J Int AIDS Soc; 2018 Nov; 21(11):e25203. PubMed ID: 30485720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing Racism's Role in the US HIV Epidemic: Qualitative Findings From Three Ending the HIV Epidemic Prevention Projects.
    Harrison SE; Muessig K; Poteat T; Koester K; Vecchio A; Paton M; Miller SJ; Pereira N; Harris O; Myers J; Campbell C; Hightow-Weidman L
    J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S46-S55. PubMed ID: 35703755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV Incidence, Prevalence, and Undiagnosed Infections in U.S. Men Who Have Sex With Men.
    Singh S; Song R; Johnson AS; McCray E; Hall HI
    Ann Intern Med; 2018 May; 168(10):685-694. PubMed ID: 29554663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New pathogen, same disparities: why COVID-19 and HIV remain prevalent in U.S. communities of colour and implications for ending the HIV epidemic.
    Millett GA
    J Int AIDS Soc; 2020 Nov; 23(11):e25639. PubMed ID: 33222424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Testing Imperative: Why the US Ending the Human Immunodeficiency Virus (HIV) Epidemic Program Needs to Renew Efforts to Expand HIV Testing in Clinical and Community-Based Settings.
    Nosyk B; Fojo AT; Kasaie P; Enns B; Trigg L; Piske M; Hutchinson AB; DiNenno EA; Zang X; Del Rio C
    Clin Infect Dis; 2023 Jun; 76(12):2206-2208. PubMed ID: 36815334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.